AP52209PU-N IMUP (C-term) antibody

See related secondary antibodies

Search for all "IMUP"

Quick Overview

Rabbit anti Human IMUP

Product Description for IMUP

Rabbit anti Human IMUP.
Properties: (C-term)
Presentation: Aff - Purified
Product is tested for Western blot / Immunoblot.

Properties for IMUP

Product Category Primary Antibodies
Quantity 0.4 ml
Synonyms C19orf33, H2RSP, HAI-2-related small protein, Hepatocyte growth factor activator inhibitor type 2-related small protein, Immortalization up-regulated protein
Presentation Aff - Purified
Reactivity Hu
Applications WB
Clonality Polyclonal
Host Rabbit
Isotype Ig
Shipping to Worldwide
PDF datasheet View Datasheet
Manufacturer Acris Antibodies GmbH
Material safety datasheet MSDS for Polyclonal Antibodies (de)

Datasheet Extract

Swiss Prot Num:
KLH conjugated synthetic peptide between 77~106 amino acids from the C-terminal region of human IMUP
Property C-term
Add. information Molecular Weight: 10897 Da
Application ELISA: 1/1000. 
Western Blot: 1/100-1/500.
Concentration lot specific
General Readings Kim, S.J., et al. Anticancer Res. 28 (2A), 865-871 (2008)
Betsunoh, H., et al. Cancer Sci. 98(4):491-498(2007)
Olsen, J.V., et al. Cell 127(3):635-648(2006)

Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
Avoid repeated freezing and thawing.
Shelf life: one year from despatch.

Protein A column, followed by peptide affinity purification
Buffer System:
PBS containing 0.09% (W/V) Sodium Azide as preservative
Liquid purified Ig fraction
Aff - Purified
This antibody recognizes Human IMUP (C-term).
Gene ID 64073

Accessory Products

Proteins and/or Positive Controls

Positive controls for IMUP (2 products)

Catalog No. Species Pres. Purity   Source  

C19orf33 Lysate

Western Blot: C19orf33 Lysate [NBL1-08268] - Western Blot experiments. 
Left-Control; Right -Over-expression Lysate for C19orf33 Protein
  Novus Biologicals Inc.

C19orf33 overexpression lysate

C19orf33 overexpression lysate
0.1 mg / €295.00
  OriGene Technologies, Inc.
  • LinkedIn